Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
142.30
+0.90 (0.64%)
At close: Nov 4, 2026

DSE:BXPHARMA Financials Overview

Millions BDT. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
53,92649,12044,39239,26734,66929,494
Revenue Growth
12.43%10.65%13.05%13.26%17.55%15.16%
Gross Profit
25,56922,04919,40317,10215,68113,816
Operating Income
11,3329,3878,2916,9026,5806,346
Net Income
8,6506,9415,8304,6145,1235,128
Earnings Per Share
19.3915.5613.0710.3411.4811.49
EPS Growth
28.90%19.06%26.34%-9.94%-0.09%45.89%

Revenue by Geography

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Jun '24 Jun '23 Jun '22 Jun '21
Bangladesh
44,89941,28136,33431,88926,331
Export
4,0742,9582,7632,6853,124
Unallocated
147.73152.62169.2695.0438.39
Total
49,12044,39239,26734,66929,494

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
5,7842,7981,2231,3021,277788.3
Total Debt
3,1634,9666,02510,61212,3717,631
Net Cash (Debt)
2,621-2,168-4,802-9,310-11,094-6,843
Net Cash Growth
------
Net Cash Per Share
5.87-4.86-10.76-20.87-24.87-15.34

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
10,4687,2238,3646,0855,2146,023
Capital Expenditures
-3,225-2,781-1,994-2,411-2,815-2,521
Free Cash Flow
7,2424,4416,3713,6742,3993,503
Free Cash Flow Growth
130.26%-30.29%73.40%53.15%-31.51%6.17%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
47.42%44.89%43.71%43.55%45.23%46.84%
Operating Margin
21.01%19.11%18.68%17.58%18.98%21.52%
Pretax Margin
20.99%18.33%16.95%15.46%19.29%21.62%
Profit Margin
16.04%14.13%13.13%11.75%14.78%17.39%
FCF Margin
13.43%9.04%14.35%9.36%6.92%11.88%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Dividend Per Share
4.7504.7504.0003.5003.5003.500
Dividend Per Share Growth
0%18.75%14.29%0%0%156.67%
Dividend Yield
3.34%5.52%3.39%2.39%2.26%1.97%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PE Ratio
7.345.539.0414.1413.4615.43
Forward PE
6.406.788.6212.0810.8316.20
P/FCF Ratio
8.778.658.2717.7528.7522.58
PS Ratio
1.180.781.191.661.992.68